arrow
M

Miguel Quintela-Fandiño

Spanish National Cancer Research Center
H指数:28
被引数:2,270

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A breast tissue-specific epigenetic clock provides accurate chronological age predictions and reveals de-correlation of age and DNA methylation in tumor-adjacent and tumor samples

乳腺组织特异性的表观遗传时钟可提供准确的年龄预测,并揭示肿瘤邻近组织和肿瘤样本中年龄与DNA甲基化的去相关性

2026-09-110
OAAI
Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations

靶向ER、FGFR和CDK4/6的协同临床试验,用于具有FGFR变异的耐药性激素阳性乳腺癌

2025-11-070
OAAI
Predicting resistance to chemotherapy using chromosomal instability signatures

使用染色体不稳定性特征预测对化疗的抗性

2025-06-230
OAAI
The impact of a high fat diet and platelet activation on pre-metastatic niche formation

高脂饮食和血小板激活对前转移微环境形成的影响

2025-04-020
OA
Constructing a high-definition patient-digital twin (PDT) in treatment-naive women with advanced cancer

在治疗初期的晚期癌症女性患者中构建高分辨率患者数字孪生(PDT)

2024-09-010
PRE
Enabling biomarkers of chromosomal instability for tumor only targeted gene panel sequencing
2024-03-220
PRE
miR-203 drives breast cancer cell differentiation

miR-203驱动乳腺癌细胞分化

2023-08-044
OAAI
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement

下一代测序检测在癌症患者中的有用性和现实世界结果: 基于临床判断的选择影响的观察性研究

2023-06-0120
OAAI
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer

RANK是ER阴性绝经后乳腺癌的不良预后标志物和治疗靶点

2023-03-073
OAAI
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A
2022-12-0711
OAAI
Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications
2021-08-179
OA